S

Summit Therapeutics
D

SMMT

22.110
USD
-0.95
(-4.12%)
مغلق
حجم التداول
142,936
الربح لكل سهم
-0
العائد الربحي
-
P/E
-98
حجم السوق
16,304,978,508
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    C
    CDXS
    -0.08000
    (-1.88%)
    4.17000 USD
    D
    DARE
    0.01000
    (0.32%)
    3.18000 USD
    E
    ENTX
    -0.09000
    (-4.11%)
    2.10000 USD
    J
    JAGX
    0.00810
    (0.94%)
    0.87420 USD
    M
    MDWD
    -1.000
    (-5.37%)
    17.630 USD
    N
    NNVC
    0.05500
    (3.82%)
    1.49500 USD
    O
    OGEN
    -0.00440
    (-1.52%)
    0.28560 USD
    المزيد
الأخبار
المقالات

العنوان: Summit Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate isridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.